The following is a news analysis Although Guillain-Barre autoimmune paralysis cases are occurring after Johnson and Johnson’s Covid-19 vaccination at a higher rate than without vaccination, federal safety advisers say the benefits still outweigh the risks. With that general guidance, […]
The following is a news analysis. When Covid-19 vaccines were being introduced to the market, it was more important than ever for safety monitors to be vigilant in looking for adverse events. After all, since the vaccines were approved quickly
(READ) Comparing Covid-19 vaccine side effects with FDA’s early list to watch Read More »
Numerous case reports of Guillain-Barre syndrome paralysis after Covid-19 vaccine have prompted scientists to warn that “all physicians” should be “vigilant in recognizing Guillain-Barré syndrome in patients who have received the AstraZeneca vaccine… our observations suggest that this clinically distinct
Scientists warn of Guillain-Barre syndrome paralysis after Covid-19 vaccination Read More »
